Jan Stoehlmacher-Williams

Learn More
BACKGROUND Previous trials have shown that anti-EGFR monoclonal antibodies can improve clinical outcomes of patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SCCHN).(More)
INTRODUCTION Afatinib is an effective first-line treatment in patients with epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC) and has shown activity in patients(More)
The FOLFOXIRI regimen (irinotecan, oxaliplatin, fluorouracil [5-FU] and folinic acid [FA]) increased the response rate and overall survival compared to FOLFIRI in patients with metastatic colorectal(More)
4070 Background: A prognostic model for metastatic gastric cancer has not been established yet. METHODS Pts with untreated gastric cancer were prospectively stratified into 3 groups: operable (OD),(More)